The FDA has approved a new drug, Vyleesi, to treat hypoactive sexual desire disorder (HSDD) in women who haven’t yet gone through menopause. Vyleesi is only the second drug that’s been approved for the treatment of HSDD. The first was Addyi, which was approved in 2015.

There are some differences among the five IUDs. The biggest is that the copper IUD (Paragard) is non-hormonal, while the other four (Mirena, LILETTA, Kyleena, and Skyla) contain a hormone called levonorgestrel, which is a type of progestin. While they all work very well to prevent pregnancy, the non-hormonal IUD can have different benefits and side effects than the hormonal IUDs, and the four hormonal IUDs have some differences among them as well. Which IUD is best for you depends on what’s most important to you.

The FDA has approved Slynd, a new version of the mini-pill that will bring much-needed flexibility to mini-pill users.

You’ve heard of chlamydia. You’ve heard of gonorrhea. But have you heard of trich (pronounced like “trick”)? Trich—which is short for trichomoniasis—is the most common non-viral STI. According to Dr. Ina Park, Associate Professor of the Department of Family and Community Medicine at the University of California San Francisco School of Medicine and medical advisor to the American Sexual Health Association, it’s more common than chlamydia and gonorrhea combined. It’s also the most common curable STI. That’s right–curable.